NFKB1 and rheumatoid arthritis: in RA patients (27, 61), and the molecular mechanisms by which these bacteria disrupt the intestinal barrier include the downregulation of tight junction protein expression in intestinal epithelial cells and the activation of the NF-κB1-mediated inflammatory pathway.